2m 2m 2m 2m 2m 2m 2m
SCINAI SP ADR (SCNI)
NASDAQ
$0.47+$0.01 (+2.65%)
Price as of Jun 03, 2026 7:53 PM EDT- $1.8MMarket Cap
- -82.02%1-Year Change
- BiotechnologyIndustry
SCINAI SP ADR (SCNI)
$0.47+$0.01 (+2.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.3M +99.24% | 658,000 N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 4.0M +220.11% | 1.2M N/A | N/A N/A | N/A N/A | |
Gross Profit | -2.7M +357.24% | -580,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 2.5M -0.20% | 2.5M -43.93% | 4.5M -14.94% | 5.3M -32.61% | |
Research and Development Expense | -2.4M -57.18% | -5.5M +6.18% | -5.2M -9.63% | -5.8M -44.25% | |
Depreciation and Amortization Expense | 1.4M -13.83% | 1.6M +220.82% | 514,000 -8.54% | 562,000 N/A | |
Total Operating Expenses | 4.9M -39.31% | 8.1M -16.98% | 9.7M +83.27% | 5.3M -78.41% | |
Operating Profit | -7.5M -12.69% | -8.6M +32.89% | -6.5M -41.23% | -11.1M N/A | |
Interest Income | 14.8M 0.00% | 14.8M N/A | N/A N/A | 10.4M N/A | |
Interest Expense | N/A N/A | N/A N/A | -343,000 N/A | N/A N/A | |
Interest Income and Expense and Net | 14.8M 0.00% | 14.8M +4,402.92% | -343,000 -103.31% | 10.4M N/A | |
Total Nonoperating Income and Expense | -765,000 -42.26% | -1.3M -486.30% | 343,000 -93.49% | 5.3M +13,062.50% | |
Income before Taxes | -7.5M -12.69% | -8.6M +32.89% | -6.5M -41.23% | -11.1M -72.33% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 250,000 -98.31% | 14.8M N/A | N/A N/A | N/A N/A | |
Net Income | -8.3M -273.21% | 4.8M +173.78% | -6.5M +12.15% | -5.8M -85.50% | |
Net Income from Continuing Operations Applicable to Common | -8.3M -273.21% | 4.8M +173.78% | -6.5M +12.15% | -5.8M -85.50% | |
Basic EPS and Net Income | 0.0009 N/A | N/A N/A | -0.004 -60.00% | -0.01 -85.71% | |
Diluted EPS and Net Income | 0.0009 N/A | N/A N/A | -0.004 -60.00% | -0.01 -85.71% | |
Basic Weighted Average Shares | 9.3B +189.55% | 3.2B +106.41% | 1.6B +107.22% | 754.1M +33.57% | |
Diluted Weighted Average Shares | 9.3B +189.55% | 3.2B +106.41% | 1.6B +107.22% | 754.1M +33.57% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.7M -15.43% | 2.0M -59.67% | 4.9M -65.40% | 14.1M -73.95% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.7M -15.43% | 2.0M -59.67% | 4.9M -65.40% | 14.1M -73.95% | |
Total Current Assets | 2.1M -14.09% | 2.4M -56.10% | 5.4M -62.09% | 14.4M -73.90% | |
Accumulated Depreciation | 5.9M +31.87% | 4.5M +58.69% | 2.8M +15.99% | 2.4M N/A | |
Property and Plant and Equipment and Net | 7.8M -15.19% | 9.2M -15.11% | 10.8M -3.73% | 11.2M -70.81% | |
Total Long-Term Assets | 9.6M -13.43% | 11.1M -8.05% | 12.0M -5.29% | 12.7M -71.50% | |
Total Assets | 11.6M -13.55% | 13.4M -23.03% | 17.5M -35.45% | 27.1M -72.82% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 382,000 N/A | |
Total Current Liabilities | 1.6M -12.24% | 1.8M +1.46% | 1.8M -23.87% | 2.3M -67.56% | |
Total Long-Term Debt | 900,000 0.00% | 900,000 0.00% | 900,000 N/A | N/A N/A | |
Total Long-Term Liabilities | 1.9M +16.40% | 1.7M -91.78% | 20.3M -23.51% | 26.5M -61.64% | |
Total Liabilities | 3.2M +0.65% | 3.2M +24.49% | 2.6M -24.56% | 3.4M N/A | |
Retained Earnings | -125.8M +7.07% | -117.5M -3.92% | -122.3M +5.61% | -115.8M -68.24% | |
Total Stockholders Equity | 8.1M -18.78% | 10.0M +318.36% | -4.6M +159.60% | -1.8M -107.54% | |
Total Shares Outstanding | 13.9B +306.59% | 3.4B +83.72% | 1.9B +87.73% | 989.3M N/A | |
Cash Flow | |||||
Cash from Operating Activities | -6.0M -4.80% | -6.3M -32.48% | -9.4M +29.14% | -7.3M -70.33% | |
Capital Expenditures | 24,000 +100.00% | 12,000 -98.12% | 637,000 -23.80% | 836,000 N/A | |
Cash from Investing Activities | -24,000 +100.00% | -12,000 -98.12% | -637,000 -23.80% | -836,000 +131.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 5.8M +67.68% | 3.4M +216.85% | 1.1M -83.97% | 6.8M -90.00% | |
Financials Ratio | |||||
Gross Margin | -202.29% +129.49% | -88.15% N/A | N/A N/A | N/A N/A | |
Operating Margin | -575.29% -56.18% | -1,312.77% N/A | N/A N/A | N/A N/A | |
Return on Assets | -66.26% -313.59% | 31.02% +206.28% | -29.19% +218.94% | -9.15% -82.09% | |
Return on Equity | -91.89% -151.81% | 177.37% -13.65% | 205.40% +482.26% | -53.73% -94.13% | |
Revenue Growth | 99.24% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 1.30 -2.11% | 1.32 -56.74% | 3.06 -50.21% | 6.15 -19.53% | |
Cash Ratio | 1.05 -3.64% | 1.09 -60.25% | 2.74 -54.55% | 6.02 -19.71% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow